AAT Recombinant Antibody

$Western blot analysis of human fetal kidney lysate. Using AAT (bsm-61403R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n$

Western blot analysis of human fetal kidney lysate. Using AAT (bsm-61403R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n

Applications

WB
IP
ICC/IF

Reactivity

Human

Overview
Catalog #	bsm-61403r
Product Name	AAT Recombinant Antibody
Applications	WB, IP, ICC/IF
Reactivity	Human
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Antithrombin 3
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	5265
Swiss Prot	P01009
Synonyms	Serpin A1; Short peptide from AAT; SPAAT; AAT.
Background	Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.
Application Dilution
WB	1:300-5000
IP	IHC-P1:200-400
ICC/IF	IHC-F1:100-500